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EDITORIAL
A tragic compromise on stem cell derivation
Jonathan D. Moreno*
Center for Biomedical Ethics, University of Virginia, P.O. Box 800758 U. Va. Health System, Charlottesville, VA 22908, USA
It appears that the ofﬁcial policy of the US government
for federally funded studies of human embryo stem (ES) cell
researchwillexcludethederivationofEScells(NationalInsti-
tuteofHealthGuidelinesforResearchUsingHumanPluripo-
tentStemCells,65FR69951(November21,2000)).Intaking
thisdecision,theNationalInstitutesof Health(NIH)isnotto
beblamed,norshouldwewringourhandsaboutthepolitical
climate that has led to it. ES cell derivation and the destruc-
tionhumanembryositentailsarecaughtinthemaelstromof
theculturallydivisiveabortiondebatethatcontinuestofester
in the United States. At the very least, however, persons who
support the promise of stem cell therapy should understand
the implications of this limitation and raise their voices in
protest against it.
Thesigniﬁcanceof thederivationcompromisehaslargely
been lost in the popular press. Even scientiﬁcally knowledge-
ablejournalistshavenotdonethepointjustice.Yetitisknown
that ES cell properties depend on the methods used to derive
them, particularly in their pluripotency. Worse, the multiple
changes that can occur within the cells as they are cultured
render their properties inconsistent and unreliable. The in-
stability associated with their growth conditions means that
ES cells cannot be simply produced centrally by a nonfeder-
ally funded source and then distributed to federally funded
researchers (in order to insulate the latter from violation of
regulations) without jeopardizing the cells’ ability to con-
tribute to tissue. Extended passage in culture seems to allow
an accumulation of mutations that change gene expression.
Perhaps the most direct lost opportunity presented by
the antiderivation policy is that of studying the process of
derivation itself. The immense decade-long effort to derive
and grow mouse ES cells needs to be undertaken for other
mammalian species. Although that work has already begun,
the time required to achieve stable ES cells from other mam-
malscouldbegreatlyshortenedbytheapplicationof thecon-
siderable intellectual, ﬁnancial, and organizational resources
of the US government medical research system.
The ethical objections to public funding of stem cell
derivation are almost shockingly weak. Consider one source,
embryonic germ (EG) cells are derived from cadaveric fetal
tissues from induced abortions. First,it has been alleged that
the knowledge that an embryo stem cells could contribute
to science might cause people to rationalize abortions and
therefore increase their frequency. Yet there is no evidence
thatthefrequencyofabortionwouldbeincreasedunderthese
conditions, and various mechanisms have been proposed to
insulate the abortion decision from the embryo donation
decision, on analogy with policies for organ donation and
harvesting. Second, it is argued the use of human materials
remaining from abortions taints the work of medical scien-
tists. Yet surely the surgeon involved in the transplant of an
organ from a shooting victim is not thereby endorsing the
murder, but rather trying to promote health and life.
Asfortheuseof“extra”embryosremainingfollowingfer-
tility treatments, there is deep disagreement among religious
traditions about the moral status of the embryo. Although
the ofﬁcial Roman Catholic doctrine that full moral status
must be conferred to the human embryo at conception is
well known, not even all Catholic theologians subscribe to
this view. And it is clear that other Christian faiths, as well as
Jewish and Islamic traditions,do not accord full moral status
to the early embryo. Surely the embryo must be respected as
a form of human life, but it does not follow that it must be
treated on a moral par with persons.
Finally,theargumentthatworkshouldinsteadgoforward
using adult stem cells cannot exclude the importance of con-
tinuingontheEScelltrack,norhaverecentpromisingevents
demonstrated that adult stem cells possess the pluripotency
of ES cells. Scientists can and must work within the con-
straints of policy decisions made in the political realm. In
this case, however, as in the case of artiﬁcial reproduction
techniques,the net result of the ban on ES cell derivation not
only slows progress without good reason. It also leaves this
area of science without the powerful imprimatur and guid-
anceofpublicoversight,acircumstancethatonlycompounds
the tragic irony of US policy on stem cell derivation.
Jonathan D. Moreno
* E-mail: jdm8n@virginia.edu
URL: http://www.med.virginia.edu/bioethics
Fax: +804 982 3971; Tel: +804 924 8274